Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Supplement—October 2024
SUPPLEMENT ISSUE
Articles

Respiratory Disease Surveillance in the Middle East and Latin America during the COVID-19 Pandemic, 2020–2022

Yeny O. Tinoco1, Tamer S. Osman, Julia S. Ampuero, Mahmoud Gazo, Victor Ocaña, Edward Chávez, Marianela Ore, Elizabeth Carrillo, Jose Santa Cruz, Carlos Delgado, Carlos Alvarez, Rommell Gonzalez, Marina S. Gonzalez, Doris Gómez, Maria E. Arango, Javier Jaramillo, Juan M. Pascale, Nicolas Aguayo, Daniel Olson, Kareen Arias, Miguel M. Cabada, William D. Graham, Tyler D. Moeller, Mohammad Alhawarat, Moutasium Hossinate, Fatima Thneibat, Mohammad Maayeh, Bassem A. Hamdy, Omar Nowar, Samuel Y. Levin, and Mayar M. Said1Comments to Author 
Author affiliation: US Naval Medical Research Unit SOUTH, Callao, Peru (Y.O. Tinoco, J.S. Ampuero, W.D. Graham, T.D. Moeller); US Naval Medical Research Unit EURAFCENT, Cairo, Egypt (T.S. Osman, B.A. Hamdy, O. Nowar, S.Y. Levin, M.M. Said); Jordan Ministry of Health, Amman, Jordan (M. Gazo, M. Alhawarat, M. Hossinate, F. Thneibat, M. Maayeh); Pachitea Health Center, Piura, Peru (V. Ocaña); Centro de Salud Militar, Trujillo, Peru (E. Chávez); Epidemiología, Comando de Salud del Ejército, Lima, Peru (M. Ore); Seguro Social de Salud-EsSalud, Lima (E. Carrillo); Dirección Regional de Salud, Cusco, Peru (J. Santa Cruz); Dirección Regional de Salud, Puerto Maldonado, Peru (C. Delgado); Dirección Regional de Salud Loreto, Loreto, Peru (C. Alvarez); Dirección Regional de Salud, Tumbes, Peru (R. Gonzalez); Secretaria de Salud del Meta, Villavicencio, Colombia (M.S. Gonzalez); Universidad de Cartagena Grupo UNIMOL, Cartagena, Colombia (D. Gómez); Universidad de Antioquia, Medellin, Colombia (M.E. Arango); Hospital Pablo Tobon Uribe, Medellin (J. Jaramillo); Gorgas Memorial Institute of Health Studies, Panama City, Panama (J.M. Pascale); Rayos de Sol NGO, Asunción, Paraguay (N. Aguayo); University of Colorado School of Medicine, Aurora, Colorado, USA (D. Olson); Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala (K. Arias); Universidad Peruana Cayetano Heredia, Cusco (M.M. Cabada); University of Texas Medical Branch, Galveston, Texas, USA (M.M. Cabada)

Main Article

Table 3

Characteristics of SARI case-patients detected as part of respiratory disease surveillance in the Middle East and Latin America during the COVID-19 pandemic, 2020–2022*

Jordan Latin America
Characteristic No. case-patients (% [95% CI]) No. case-patients (% [95% CI])
Total SARI cases
8,523
687
Sex
M 4,593 (53.9 [52.5–55.3]) 368 (53.6 [48.5–58.7])
F
 3,930 (46.1 [44.7–47.6])
319 (46.4 [41.5–51.8])
Age group
<16 2,931 (34.4 [32.7–36.1]) 473 (68.9 [64.7–73.0])
16–50 1,780 (20.9 [19.0–22.8]) 123 (17.9 [11.1–24.7])
>50
 3,812 (44.7 [43.1–46.3])
91 (13.2 [6.3–20.1])
Positive test result
Influenza, n = 8,523 219 (2.6 [2.3–2.9]) 52 (7.6 [4.0–14.8])
SARS-CoV-2, n = 8,144 1,361 (16.7 [15.9–17.5]) 79 (11.5 [4.5–18.5])
RSV, n = 8,147 448 (5.5 [5.0–6.0]) 134 (19.5 [12.8–26.2])
Other respiratory pathogens, n = 8,147 4,255 (52.2 [51.1–53.3]) 556 (80.9 [77.6–84.2])

*ILI, influenza-like illness; RSV, respiratory syncytial virus; SARI, severe acute respiratory infection.

Main Article

1These authors contributed equally to this article.

Page created: October 17, 2024
Page updated: November 11, 2024
Page reviewed: November 11, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external